Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada

• Published in: Cancer genetics 2017-01, Vol.210, p.1-8
• Main Authors: Huang, Steven J, Bergin, Krystal, Smith, Adam C, Gerrie, Alina S, Bruyere, Helene, Dalal, Chinmay B, Sugioka, Daniele K, Hrynchak, Monica, Ramadan, Khaled M, Karsan, Aly, Gillan, Tanya L, Toze, Cynthia L
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; British Columbia - epidemiology; Chronic lymphocytic leukemia; Clonal Evolution; Female; fluorescence in situ hybridization; Hematology, Oncology and Palliative Medicine; Humans; In Situ Hybridization, Fluorescence - methods; Interphase; Leukemia, Lymphocytic, Chronic, B-Cell - genetics; Leukemia, Lymphocytic, Chronic, B-Cell - mortality; Male; Medical Education; Middle Aged; overall survival; population; Prognosis; Survival Analysis
• ISSN: 2210-7762; 2210-7770
• DOI: 10.1016/j.cancergen.2016.10.006

Abstract This study evaluates prognostic markers as predictors of clonal evolution (CE) and assesses the impact of CE on overall survival (OS) in a population-based cohort of 159 consecutive eligible patients with chronic lymphocytic leukemia (CLL) obtained from the British Columbia Provincial CLL Database. CE was detected by interphase fluorescence in situ hybridization (FISH) in 34/159 patients (21%) with 65% of CE patients acquiring deletion 17p or 11q. CD38 positive status (≥ 30%) on flow cytometry predicted 2.7 times increased risk of high-risk CE (acquisition of deletion 17p or 11q) on multivariate analysis. Prior CLL therapy was not a significant predictor of CE. CE was associated with 4.1 times greater risk of death when analyzed as a time-dependent variable for OS after adjusting for age, lymphocyte count, and FISH timing. High-risk CE was associated with worse OS while acquisition of low/intermediate-risk abnormalities (trisomy 12, deletion 13q, and IGH translocation) had no difference in OS. Our study demonstrates the negative impact of CE detected by FISH on OS in this population-based cohort. This data provides support for repeating FISH testing during CLL follow-up as patients with high-risk CE have reduced survival and may require closer observation.